Categories AlphaGraphs, Earnings, Finance

Genworth Financial reports Q2 2023 results. Here’s what you need to know

Genworth Financial, Inc. (NYSE: GNW) has reported lower earnings for the second quarter of 2023 when the insurance service provider’s revenues remained unchanged. The company repurchased around $112 million of its stock during the quarter.

Genworth Financial Q2 2023 earnings infographic

Net income available to shareholders decreased to $137 million or $0.29 per share in the June quarter from $159 million or $0.31 per share in the prior-year period.

Meanwhile, second-quarter revenues remained unchanged at $1.90 billion. Premium revenues declined 2% while net investment income remained flat.

“Enact continues to perform well and has increased its planned capital return to Genworth and other shareholders. Based on strong free cash flow, the Genworth Board increased the share repurchase authorization by $350 million,” said Genworth’s CEO Tom McInerney.

Prior Performance

  • Genworth Financial Q4 2022 earnings infographic
  • Genworth Financial Q3 2022 earnings infographics

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top